November 22, 2024 The Best Source of News, Culture, Lifestyle for Culver City, Mar Vista, Del Rey, Palms and West Los Angeles

Cedars-Sinai Develops New Gene Therapy to Combat Lou Gehrig’s Disease

Cedars-Sinai announced Thursday its regenerative medicine investigators have received approval from the U.S. Food and Drug Administration to test a combination stem cell-gene therapy they developed to stall the progression of Lou Gehrig’s disease.

The approval allows patients to receive a new investigational drug in a few months when the study begins at the Cedar-Sinai Board of Governors Regenerative Medicine Institute.

This will be the first clinical trial to test the safety of this type of therapy, developed with the intention of preserving leg mobility in patients with Lou Gehrig’s disease, also called amyotrophic lateral sclerosis, which attacks motor neurons, cells that control muscles.

Enrollment could begin by the end of this year.

There is no effective treatment for the disease, only medications to alleviate symptoms, such as muscle spasms, or mechanical devices to help patients breathe. As a result, this clinical trial is seen by many as significant.

“Any time you’re trying to treat an incurable disease, it is a long shot, but we believe the rationale behind our new approach is strong,” said Clive Svendsen, director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, who has spent a dozen years developing the new approach.

The new approach, funded by the California Institute for Regenerative Medicine and outlined in a 4,600-page application to the FDA, involves engineering stem cells to produce an important protein — glial cell line derived neurotrophic factor. The stem cells producing GDNF then can protect the motor neurons that allow impulses to pass from the brain or spinal cord to a muscle.

When a healthy person wants to move a leg, for example, the brain sends a signal along that pathway to the motor neuron that enables the movement. Patients with ALS develop progressive paralysis as the disease causes motor neurons to die.

Motor neurons that die in ALS don’t exist in a vacuum — they have support cells called glia that enable the motor neurons to live and operate,” said Svendsen, the Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine.

“What we and others have found in ALS is that the support cells become sick and lack certain proteins that keep motor neurons alive. When the support cells die, the motor neurons also die, causing paralysis that gets worse and worse until the patient can no longer move.”

Svendsen and his team reasoned that if they could keep motor neurons alive by providing the supporting glial cells that make the necessary protein, then perhaps they could improve leg mobility.

Their theory spurred the team to develop this combined stem cell and gene therapy approach. The stem cells engineered to produce GDNF are replicated until billions of cells are formed.

When the protein-enhanced stem cells are infused into the patient’s spinal cord, they generate glial support cells that produce GDNF. The hope is that these support cells will, in turn, keep the motor neurons alive.

“This is a highly innovative approach to a disease that has mystified medicine for generations,” said Dr. Shlomo Melmed, Cedars-Sinai executive vice president for Academic Affairs, dean of the medical faculty and the Helene A. and Philip E. Hixon Distinguished Chair in Investigative Medicine.

The combination of cutting-edge stem cell science, developing a new device to inject the cells, our outstanding research laboratories and the direct involvement of neuroscientists, neurosurgeons and neurologists made this CIRM-funded project possible.”

The stem cell implantations for ALS patients involved in the clinical trial could begin by the end of the year, Svendsen said.

Participants will come from the ALS Clinic at Cedars-Sinai, and the trial will be led by Dr. Robert Baloh and Peggy Allred. The neurosurgical team will be led by Dr. J. Patrick Johnson.

Patients eligible to be considered for the trial must be experiencing ALS-caused weakness in their legs. Cell implantations will take place during a five-hour surgical procedure in which a neurosurgeon will remove a piece of bone in the lumbar region of the patient’s lower back.

Using an investigational device developed specifically for this trial, the surgeon will inject the stem cells directly into the patient’s spinal cord in a section that governs movement on only one side of the body.

Neither the patients nor the physicians caring for the patients will know which side has received the stem cells.

“We will follow the patients for a year and measure the strength in each leg,” Svendsen said.

“In ALS, usually the legs lose strength at the same time. This is a small safety trial to ensure the cells releasing GDNF do not have any negative effects on leg function. If safe, we plan a larger future trial to see if this therapy can improve strength in the treated leg.”

Patients seeking information about potentially participating in the clinical trial should call (310) 423-1791.

The research leading to the clinical trial has been funded by a $16.8 million grant from the California Institute for Regenerative Medicine.

 

Cedars-Sinai

Related Posts

Breakaway Café Opens New Venice Location with Beachside Grab-and-Go Window

November 20, 2024

November 20, 2024

Bayse Brothers Bring Their Signature Breakfast Dishes and Good Vibes to Venice Breakaway Café, a popular breakfast and lunch eatery...

Last Minute Additions to the Best Thanksgiving 2024 Feasts and Pies To Go

November 20, 2024

November 20, 2024

If Other Faves are Sold Out, Here’s All The Quality Places to Try Now Celebrity chefs Susan Feniger and Mary...

Everytable’s Holiday Meal Collaboration To Support LA’s Unhoused Youth

November 20, 2024

November 20, 2024

Chef Created Thanksgiving Meal Benefits My Friend’s Place. Everytable, the mission-driven company committed to making scratch-cooked, nutritious meals accessible to...

Los Angeles City Council Codifies Sanctuary Protections for Migrants with New Citywide Ordinance

November 19, 2024

November 19, 2024

Mayor Bass Prioritized the Ordinance after Trump’s Mass Deportation Threats The Los Angeles City Council voted unanimously Tuesday to officially...

The Palms Community Council’s Executive Committee Schedules Special Meeting for Nov. 20

November 19, 2024

November 19, 2024

Meeting to Address Open Board Positions and Committee Updates The Executive Committee will hold a special meeting on Wednesday, Nov....

Hammer Museum Presents 10th Edition of MoMA Contenders: Screenings, Conversations with Top Filmmakers

November 19, 2024

November 19, 2024

Lineup Features Films by Steve McQueen, Sean Baker, and Brady Corbett The Hammer Museum will host the 10th edition of...

Film Review: Wicked

November 19, 2024

November 19, 2024

By Dolores Quintana Director John Chu (Crazy Rich Asians, In The Heights) has crafted an effervescent take on the blockbuster...

Randy’s Donuts Arrives in Culver City with Free Donuts and a $250 Gift Card Giveaway

November 19, 2024

November 19, 2024

Grand Opening on November 19 Includes Sweet Giveaways Starting at 6:00 a.m. The time is finally here. Randy’s Donuts is...

Nicole Nagel’s Futuristic Eric Moss Designed Brentwood Home To Hit Auction Block

November 18, 2024

November 18, 2024

The Spaceship-Like Property Heads to Auction With No Reserve in December German actress Nicole Nagel, who was part of the...

LA Controller Kenneth Meija: City Left $513 Million of Homelessness Budget Unspent

November 18, 2024

November 18, 2024

Inefficiencies Blamed for Underspending Despite Record Allocation in FY2024  The City of Los Angeles hasn’t spent over half of its...

West LA College Expands Zero-Cost Textbook Programs with $600K Grant

November 18, 2024

November 18, 2024

College Aims for 50 Zero-Cost Textbook Programs by 2025  West Los Angeles College (West) is expanding its zero-cost textbook program...

(Video) At Vistamar School – Discover the way high school should be

November 18, 2024

November 18, 2024

Students achieve remarkable outcomes with our strong academics, small classes, andpersonalized approach. Our graduates don’t just attend college—they excel. Vistamar’sunique...

(Video) Celebrating 60 Years of Excellence in Education

November 18, 2024

November 18, 2024

Join our international community! Preschool through 12th grade, private school in West Los Angeles and Pacific Palisades, No French knowledge required...

Missing Person Alert: Authorities Seek Help to Find Michelle Lerner, 63, in Culver City

November 18, 2024

November 18, 2024

Woman Was Last Seen Near Prospect Avenue and Venice Boulevard  Authorities are asking for the public’s assistance in locating a...

Lodge Bread To Open New Beverly Hills Location on November 22

November 18, 2024

November 18, 2024

Popular Bakery Will Offer Its Signature Sourdoughs and Pastries  Lodge Bread, a highly regarded West Los Angeles bakery and café,...